| Dr Jack Mark Bernstein, MD | |
|
3533 Southern Blvd Ste 4200, Kettering, OH 45429-1272 | |
| (937) 572-7648 | |
| (937) 832-8279 |
| Full Name | Dr Jack Mark Bernstein |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 3533 Southern Blvd Ste 4200, Kettering, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043212772 | NPI | - | NPPES |
| 0438922 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 35-055759 (Ohio) | Primary |
| Entity Name | Infectious Diseases Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023061207 PECOS PAC ID: 3476454331 Enrollment ID: O20040115000252 |
News Archive
On Friday, July 16, U.S. Department of Health and Human Services Secretary Kathleen Sebelius and U.S. Attorney General Eric Holder will kick off the first in a series of day-long summits bringing together a wide array of federal, state, and local partners, beneficiaries, providers, and other interested parties to discuss innovative ways to eliminate fraud within the U.S. health care system. The summit will include educational panels featuring law enforcement officials, consumer experts, providers, and key government agencies.
Scottsdale Healthcare surgeon Robin Blackstone, MD is the new president-elect of the American Society for Metabolic & Bariatric Surgery (ASMBS), recognizing her leadership and expertise in the field of weight-loss surgery.
Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jack Mark Bernstein, MD 3533 Southern Blvd Ste 4200, Kettering, OH 45429-1272 Ph: (937) 572-7648 | Dr Jack Mark Bernstein, MD 3533 Southern Blvd Ste 4200, Kettering, OH 45429-1272 Ph: (937) 572-7648 |
News Archive
On Friday, July 16, U.S. Department of Health and Human Services Secretary Kathleen Sebelius and U.S. Attorney General Eric Holder will kick off the first in a series of day-long summits bringing together a wide array of federal, state, and local partners, beneficiaries, providers, and other interested parties to discuss innovative ways to eliminate fraud within the U.S. health care system. The summit will include educational panels featuring law enforcement officials, consumer experts, providers, and key government agencies.
Scottsdale Healthcare surgeon Robin Blackstone, MD is the new president-elect of the American Society for Metabolic & Bariatric Surgery (ASMBS), recognizing her leadership and expertise in the field of weight-loss surgery.
Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer.
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
› Verified 3 days ago
Dr. Heather D Riggs Carter, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3700 Southern Bvld., Ste. 401, Kettering, OH 45429 Phone: 855-500-2873 Fax: 937-281-3913 | |
Dr. Jeremy Lawton Chapman, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-6665 Fax: 937-395-6668 | |
Saleem Ahmad, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 540 Lincoln Park Blvd, Suite 200, Kettering, OH 45429 Phone: 937-298-8058 Fax: 937-298-5638 | |
Calvert Raymond Busch, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 1380 E Stroop Rd, Kettering, OH 45429 Phone: 937-293-3486 Fax: 937-293-3605 | |
Dr. Hemant M Shah, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3533 Southern Blvd Ste 5800, Kettering, OH 45429 Phone: 937-439-3600 Fax: 937-741-8366 | |
Martin Burbank, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-384-6800 Fax: 937-384-6938 | |
Naveen K Vijayam, Infectious Disease Medicare: Medicare Enrolled Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-6665 Fax: 937-395-6668 |